Dr. Mendieta's stem cell and peptide claims, fact-checked

What did @antwan_shirley actually say?

The video features Dr. Constantino Mendieta discussing his approach to patient care through what he calls healing "from within." He made several distinct claims worth unpacking separately. He said peptides are "the building block for all the different hormones, all the different chemicals, neurotransmitters that we have." He disclosed personal diagnoses of black mold, heavy metals including mercury, lead, and arsenic in his own body. He also acknowledged that stem cell therapy exists in a regulatory gray zone, noting practitioners "can't make claims on it" and referring to them as "regenerative cells" instead. On the whole, this is a mix of loosely accurate biology, some legitimate regulatory candor, and a few claims that deserve more scrutiny than a 90-second video can provide.

Does the science back this up?

Partly, yes. Peptides are short chains of amino acids, and some do act as signaling molecules that influence hormone release and neurotransmission. That part is defensible. The claim that peptides are "the building block" for all hormones and neurotransmitters is an oversimplification that collapses real biochemical complexity into a marketing-friendly soundbite.

On stem cells, the science is genuinely unsettled. The FDA has repeatedly warned that many clinics offering stem cell or "regenerative cell" treatments lack adequate clinical evidence. A 2021 review by Marks et al. in Stem Cell Reports found that the majority of direct-to-consumer stem cell clinics in the U.S. operated outside established clinical trial frameworks. Dr. Mendieta actually acknowledged this gap himself, which is more honest than most practitioners in this space tend to be.

The heavy metals claim is harder to evaluate without lab context. Elevated mercury, lead, and arsenic are real clinical concerns, but self-reporting a diagnosis in a promotional video without specifying testing methodology or reference ranges tells us very little about actual exposure levels or clinical significance.

What did they get wrong (or right)?

The framing that peptides are universally "the building block" for hormones and neurotransmitters gets credit for being directionally accurate but loses points for being imprecise. Steroid hormones, for instance, are derived from cholesterol, not peptides. Dopamine and serotonin are monoamines. The category of peptide hormones is real and significant, including insulin, oxytocin, and growth hormone-releasing peptides, but the blanket statement is too broad to hold up scientifically.

What he got right: the regulatory candor around stem cells is refreshing. He did not promise outcomes. He did not claim regenerative cells cure disease. He said the chapter "is still to be written," which is an accurate description of where the evidence base sits in 2024.

What deserves skepticism: the personal heavy metals and black mold disclosure, presented in a promotional context, functions as an implicit testimonial. It suggests that his personal detox journey validates the therapies he offers. That is a persuasion move, not a clinical argument. Personal anecdote is not evidence, regardless of the speaker's credentials.

What should you actually know?

If you are considering peptide therapy or regenerative medicine through any clinic, here is what the evidence actually supports as of now.

• Peptides like BPC-157 and TB-500 show promising results in animal models for tissue repair and inflammation, but robust human clinical trial data remains limited. A 2018 review by Sikiric et al. in Current Pharmaceutical Design covered BPC-157's mechanisms but acknowledged the human data gap.
• Growth hormone secretagogues like CJC-1295 and ipamorelin stimulate GH release and have been studied in adults with GH deficiency, but off-label use for general "optimization" carries risks including fluid retention, insulin resistance, and unknown long-term effects.
• The FDA classifies most peptides used in longevity clinics as unapproved drugs when compounded without specific patient need. Regulatory status matters for your safety, not just for legal reasons.
• Heavy metal testing is a legitimate clinical tool when conducted through validated labs with proper reference ranges. The interpretation requires a physician who understands occupational exposure history, not just a panel of numbers.
• "Regenerative cells" is a term some clinics use to sidestep FDA restrictions on stem cell marketing. That does not mean the therapy is ineffective, but it does mean you should ask hard questions about the evidence before paying for it.

Bottom line

Dr. Mendieta's framing is more cautious than many practitioners in this space, and his acknowledgment of regulatory limitations on stem cell claims is genuinely worth noting. But promotional content is not a substitute for a clinical consultation, and the biochemistry here is presented at a level of simplicity that could mislead patients into thinking these therapies are better understood than they currently are. If any of this interests you, the right move is a conversation with a licensed provider who can review your actual labs, not a 90-second Instagram clip.